Authors: Dillman, RO Soori, G Wiemann, MC Schulof, R Dobbs, TW Ruben, RH DePriest, CB Church, C

Citation: Ro. Dillman et al., Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, intravenous combination chemotherapy, and oral tamoxifen in the treatment of metastatic melanoma: Final results of Cancer Biotherapy Research Group94-11, CANC BIO R, 15(5), 2000, pp. 487-494